Atopic dermatitis
Conditions
Interventions
Participants were allocated into the control group and study group through simple randomization using the Randomizer platform. Single-blind, randomized, controlled clinical trial (researcher blind) St
Sponsors
Complexo Hospital de Clínicas da Universidade Federal do Paraná
Complexo Hospital de Clínicas da Universidade Federal do Paraná
Eligibility
Age
No minimum to 15 Years
Inclusion criteria
Inclusion criteria: Children under the age of 15 and their respective primary caregiver who attend the consultation at the Pediatric Dermatology service of the Hospital de Clínicas Complex; children who meet the Hanifin and Rajka criteria for the clinical diagnosis of atopic dermatitis; children who do not have other chronic diseases, with the exception of mild asthma and rhinitis; children accompanied by their primary caregivers; literate caregivers who answer the Quality of Life questionnaires; guardians who have a cell phone that supports the Whatsapp® application and have enabled the read confirmation option and who have an active phone line and mobile Internet or WiFi available; who agree to participate and sign the Informed Consent Form and Informed Consent Form, when applicable
Exclusion criteria
Exclusion criteria: They started using immunosuppressants during the evaluation period or up to 2 months before inclusion in the study; who do not return for revaluations in the specified period; withdraw the Free and Informed Consent form and the Free and Informed Consent Term
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in the severity of atopic dermatitis, through the receipt of text messages with information about the disease, based on the finding of a significantly statistical decrease in the severity scores of atopic dermatitis | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in the quality of life of participants with atopic dermatitis, through the receipt of text messages with information about the disease, based on the observation of a significantly statistical increase in the scores in the quality of life questionnaires in atopic dermatitis. | — |
Countries
Brazil
Contacts
Public ContactRenata Imoto
Complexo Hospital de Clínicas da Universidade Federal do Paraná
Outcome results
None listed